Thyroid Associated Orbitopathy with Ocular Myasthenia in Primary Hypothyroidism: Keep Those Eyes Open
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Neuromyelitis Optica in Patients with Myasthenia Gravis Who Underwent Thymectomy
ORIGINAL CONTRIBUTION Neuromyelitis Optica in Patients With Myasthenia Gravis Who Underwent Thymectomy Ilya Kister, MD; Sandeep Gulati, MD; Cavit Boz, MD; Roberto Bergamaschi, MD; Guiseppe Piccolo, MD; Joel Oger, MD; Michael L. Swerdlow, MD Background: Myasthenia gravis (MG) and neuromy- Patients: Four patients with MG who underwent elitis optica (NMO, also known as Devic disease) are rare thymectomy. autoimmune disorders, with upper-limit prevalence es- timates in the general population of 15 per 100 000 and Interventions: None. 5 per 100 000, respectively. To our knowledge, an asso- ciation between these diseases has not been previously Results: The prevalence of MG within the published co- reported. hort of patients with NMO is more than 150 times higher than that in the general population. Objectives: To describe 4 patients with MG who de- Conclusion: Dysregulation of B-cell autoimmunity in my- veloped NMO after thymectomy and to analyze possible asthenia, possibly exacerbated by loss of control over au- causes of apparent increased prevalence of NMO among toreactive cells as a result of thymectomy, may predis- patients with MG. pose patients to the development of NMO. Design: Case series. Arch Neurol. 2006;63:851-856 EUROMYELITIS OPTICA REPORT OF CASES (NMO) is characterized by 1 or more attacks of CASE 1 optic neuritis (ON) and myelitis. It can be dif- An African American woman with mild Nferentiated from multiple sclerosis (MS) asthma, distant history of smoking and with the aid of magnetic resonance imag- cocaine snorting, and family history of ing (MRI),1-3 cerebrospinal fluid anal- MS in her mother developed symptoms ysis4-8 and NMO-IgG antibody.9 The of ocular myasthenia at age 38 years. -
Contri Butors
CONTRI BUTORS A Bhagwati Department of Medicine President, Urological Society of India Honorary Physician LLRM Medical College (2008-2009) Rhatia Hospital, Wockhardt Hospitals and Meerut, Uttar Pradesh, India President, Indian Medical Association Motiben Dalvi Hospitals (2007-2008) S-nt. Adil Farooq Mumbai, Maharashtra, India Council Member, World Medical Aditya Prakash Misra Association(WMA) A Kader Sahib Senior Consultant, Physician Consultant Cardiologist Ajinkya Borhade Jessa Ram Hospital, Hospital and Ayesha Hospital Apollo New Delhi, India PG, DNB, Medicine Trichy, Tamil Nadu, India Sundaram Arulrhaj Hospitals AG Unnikrishnan Thoothukudi, Tamil Nadu, India A Muruganathan Endocrinologist and CEO Adjunct Professor Head of Patient Care AK Agarwal Thmil Nadu Dr MGR Medical University Research and Education Professor and Head Tirupur, Thmil Nadu, India Chellaram Diabetes Institute School of Medical Science and Research Pune, Maharashtra, India A R Vijayaku mar (SMS & R) Rtd. HOD and Professor Medicine Agam Vora Sharda Hospital and University Greater Noida, Uttar Pradesh, India Coimbatore Medical College and Asst. Hon. & In Charge - Dept of Chest & PSG Institute of Medical Science and TB, Dr. RN Cooper Muni. Gen. Hospital, Research, Coimbatore Mumbai, Maharashtra, India Akashdeep Singh Consulting Physician Professor Associate Professor GKNM Hospital, Coimbatore Department of Chest & TB Department of Pulmonary Medicine Member, Research Committee KiSomaiya Dayanand Medical College and Hospital Association of Physicians of India Medical -
Targeting the Rare Co-Occurrence of Myasthenia Gravis and Graves’ Disease with Radioactive Iodine Therapy
ID: 21-0046 -21-0046 A E S Arcellana and others Myasthenia gravis, Graves’ ID: 21-0046; July 2021 disease association DOI: 10.1530/EDM-21-0046 Dual attack: targeting the rare co-occurrence of myasthenia gravis and Graves’ disease with radioactive iodine therapy Correspondence Anna Elvira S Arcellana 1, Karen Joy B Adiao2 and Myrna Buenaluz-Sedurante1 should be addressed to A E S Arcellana 1Division of Endocrinology, Diabetes and Metabolism, Department of Medicine and 2Department of Neurosciences, Email University of the Philippines-Manila, Philippine General Hospital, Manila, Philippines [email protected] Summary Occasionally, autoimmune disorders can come in twos. This double trouble creates unique challenges. Myasthenia gravis co-existing with autoimmune thyroid disease occurs in only about 0.14–0.2% of cases. The patient is a 27-year- old man with a 2-month history of bilateral ptosis, diplopia, with episodes of easy fatigability, palpitations, and heat intolerance. On physical exam, the patient had an enlarged thyroid gland. Myasthenia gravis was established based on the presence of ptosis with weakness of the intraocular muscles, abnormal fatigability, and a repetitive nerve stimulation studyindicatedneuromuscularjunctiondisease.Episodesoffluctuatingrightshoulderweaknesswerealsonoted.He wasalsofoundtohaveelevatedFT3,FT4,andasuppressedTSH.Thyroidultrasoundrevealedthyromegalywithdiffused parenchymal disease. Thyroid scintigraphy showed increased uptake function at 72.4% uptake at 24 h. TRAb was positive at4.1U/L.Patientwasstartedonpyridostigminewhichledtoasignificantreductioninthefrequencyofocularmuscle weakness.Methimazolewasalsoinitiated.Radioactiveiodineat14.9mciwasinstitutedforthedefinitivemanagementof hyperthyroidism. After RAI, there was abatement of the hyperthyroid symptoms, as well as improvement in the status of the myasthenia gravis, with ptosis, diplopia, and right arm weakness hardly occurring thereafter despite the reduction of the pyridostigmine dose based on a symptom diary and medication intake record. -
Chronic Arsenicosis in India
Seminar: Chronic Arsenicosis in India EEpidemiologypidemiology andand preventionprevention ofof chronicchronic arsenicosis:arsenicosis: AnAn IndianIndian pperspectiveerspective PPramitramit GGhosh,hosh, CChinmoyihinmoyi RRoyoy2, NNilayilay KKantianti DDasas1, SSujitujit RRanjananjan SSenguptaengupta3 Departments of Community Medicine and 1Dermatology, Medical College, Kolkata-700 073, 2State Water Investigation Directorate, Govt. of West Bengal, 3Dept. of Dermatology, IPGMER and SSKM Hospital, Kolkata-700 020, India AAddressddress fforor ccorrespondence:orrespondence: Nilay Kanti Das, Devitala Road, Majerpara, Ishapore-743 144, India. E-mail: [email protected] ABSTRACT Arsenicosis is a global problem but the recent data reveals that Asian countries, India and Bangladesh in particular, are the worst sufferers. In India, the state of West Bengal bears the major brunt of the problem, with almost 12 districts presently in the grip of this deadly disease. Recent reports suggest that other states in the Ganga/Brahmaputra plains are also showing alarming levels of arsenic in ground water. In West Bengal, the majority of registered cases are from the district of Nadia, and the maximum number of deaths due to arsenicosis is from the district of South 24 Paraganas. The reason behind the problem in India is thought to be mainly geogenic, though there are instances of reported anthropogenic contamination of arsenic from industrial sources. The reason for leaching of arsenic in ground water is attributed to various factors, including excessive withdrawal of ground water for the purpose of irrigation, use of bio-control agents and phosphate fertilizers. It remains a mystery why all those who are exposed to arsenic-contaminated water do not develop the full-blown disease. Various host factors, such as nutritional status, socioeconomic status, and genetic polymorphism, are thought to make a person vulnerable to the disease. -
Laparoscopic Adrenalectomy: a Single Center Experience
Original Article Laparoscopic adrenalectomy: A single center experience Suresh Kumar, Moley K Bera, Mukesh K Vijay, Arindam Dutt, Punit Tiwari, Anup K Kundu Department of Urology, Institute of Post-Graduate Medical Education and Research (IPGMER) and Seth Sukhlal Karnani Memorial Hospital (SSKM), Kolkata - 700 020, India Address for correspondence: Dr. Suresh Kumar, 601 Doctors PG Hostel, 242 AJC Bose Road, IPGMER and SSKM Hospital, Kolkata - 700 020, West Bengal, India. E-mail: [email protected] Abstract performed via the transperitoneal or retroperitoneal route- the former via the lateral or anterior approach and the latter AIMS: To evaluate the efficacy and safety of laparoscopic via the posterior approach. Robot-assisted laparoscopic adrenalectomy in benign adrenal disorders. METHODS adrenalectomy may also be performed if facilities are AND MATERIAL: Since July 2007, twenty patients available. Each technique has its own advantages and have undergone laparoscopic adrenalectomy for various benign adrenal disorders at our institution. Every patient disadvantages. It is now an established fact that different underwent contrast enhanced CT-abdomen. Serum advantages of the laparoscopic approach include less corticosteroid levels were conducted in all, and urinary morbidity, better cosmesis, reduction in wound infection, metanephrines, normetanephrines and VMA levels minimal need for analgesia, decreased hospital stay and early were performed in suspected pheochromocytoma. All return to work.[2-4] We report our experience of laparoscopic the patients underwent laparoscopic adrenalectomy via adrenalectomy using the transperitoneal approach in 20 the transperitoneal approach. : The patients RESULTS patients with different adrenal pathology. This prospective were in the age range of 18-57 years, eleven males study was conducted in our Urology Department to evaluate and nine females, seven right, eleven left, two bilateral. -
2020 Lahiri Et Al Hallucinatory Palinopsia and Paroxysmal Oscillopsia
cortex 124 (2020) 188e192 Available online at www.sciencedirect.com ScienceDirect Journal homepage: www.elsevier.com/locate/cortex Hallucinatory palinopsia and paroxysmal oscillopsia as initial manifestations of sporadic Creutzfeldt-Jakob disease: A case study Durjoy Lahiri a, Souvik Dubey a, Biman K. Ray a and Alfredo Ardila b,c,* a Bangur Institute of Neurosciences, IPGMER and SSKM Hospital, Kolkata, India b Sechenov University, Moscow, Russia c Albizu University, Miami, FL, USA article info abstract Article history: Background: Heidenhain variant of Cruetzfeldt Jacob Disease is a rare phenotype of the Received 4 August 2019 disease. Early and isolated visual symptoms characterize this particular variant of CJD. Reviewed 7 October 2019 Other typical symptoms pertaining to muti-axial neurological involvement usually appear Revised 9 October 2019 in following weeks to months. Commonly reported visual difficulties in Heidenhain variant Accepted 14 November 2019 are visual dimness, restricted field of vision, agnosias and spatial difficulties. We report Action editor Peter Garrard here a case of Heidenhain variant that presented with very unusual symptoms of pal- Published online 13 December 2019 inopsia and oscillopsia. Case presentation: A 62-year-old male patient presented with symptoms of prolonged af- Keywords: terimages following removal of visual stimulus. It was later on accompanied by intermit- Creutzfeldt Jacob disease tent sense of unstable visual scene. He underwent surgery in suspicion of cataratcogenous Heidenhain variant vision loss but with no improvement in symptoms. Additionally he developed symptoms of Oscillopsia cerebellar ataxia, cognitive decline and multifocal myoclonus in subsequent weeks. On the Palinopsia basis of suggestive MRI findings in brain, typical EEG changes and a positive result of 14-3-3 protein in CSF, he was eventually diagnosed as sCJD. -
Myasthenia Gravis
A Guide for Patients and Families What is... Myasthenia Gravis Myasthenia gravis (MG) is a chronic autoimmune MG is not inherited, and it is not contagious. Although disease — a disease that occurs when the immune MG is not hereditary, genetic susceptibility appears to system mistakenly attacks the body’s own tissues. play a role in it. Occasionally, the disease may occur in more than one member of the same family. In MG, the immune system attacks and interrupts the connection between nerve and muscle, called the MG causes weakness in muscles that control the neuromuscular junction (NMJ). This causes weakness eyes, face, neck, and limbs. Symptoms include partial in the skeletal muscles, which are responsible for paralysis of eye movements, double vision, and droopy breathing and moving parts of the body. eyelids, as well as weakness and fatigue in neck and jaws with problems in chewing, swallowing, and holding In most cases of MG, the immune system targets the up the head. acetylcholine receptor — a protein on muscle cells that is required for muscle contraction. Muscle weakness in MG gets worse with exertion and improves with rest. About 85 percent of people with MG have antibodies against the acetylcholine receptor in their blood. The Approximately 10-20 percent of people with antibodies target and destroy many of the acetylcholine MG experience at least one myasthenic crisis, an receptors on muscle. Consequently, the muscle’s emergency in which the muscles that control breathing response to repeated nerve signals declines with time, weaken to the point where the individual requires a and the muscles become weak and tired. -
CTRI Trial Data
PDF of Trial CTRI Website URL - http://ctri.nic.in Clinical Trial Details (PDF Generation Date :- Fri, 01 Oct 2021 18:39:00 GMT) CTRI Number CTRI/2019/03/017947 [Registered on: 06/03/2019] - Trial Registered Prospectively Last Modified On 26/02/2019 Post Graduate Thesis Yes Type of Trial Interventional Type of Study Drug Study Design Randomized, Parallel Group, Active Controlled Trial Public Title of Study Comparison between Buprenorphine skin patch and intravenous Paracetamol for pain relief after major reconstructive plastic surgery Scientific Title of Comparison between transdermal Buprenorphine and intravenous Paracetamol for post-operative Study analgesia after major plastic reconstructive surgery under General Anaesthesia - A randomised double blind controlled trial. Secondary IDs if Any Secondary ID Identifier NIL NIL Details of Principal Details of Principal Investigator Investigator or overall Name Arghya Maity Trial Coordinator (multi-center study) Designation POST GRADUATE TRAINEE Affiliation Institute of Post Graduate Medical Education and Research Address PGT Room Dept of Anaesthesiology Main Block IPGMER and SSKM Hospital Room no 524 Doctors Hostel IPGMER and SSKM Hospital Kolkata WEST BENGAL 700129 India Phone 9051207925 Fax Email [email protected] Details Contact Details Contact Person (Scientific Query) Person (Scientific Name Sarbari Swaika Query) Designation Associate Professor Affiliation Institute of Post Graduate Medical Education and Research Address Faculty Room Dept of Anaesthesiology Main Block IPGMER -
Medicine Update 2016) Brothers
Progress in Medicine 2016 (Medicine Update 2016) Brothers Jaypee For Private Circulation Only Progress in Medicine and Medicine Update 2016 The publication of this book has been made possible by Unconditional educational grant from: USV Limited The scientific committee is also thankful for the unconditionalBrothers grants from: India Medtronic Abbott Healthcare Mankind Pharma MICRO Labs Cipla Limited Dr Reddy’s Lab Eris Lifesciences, Intas Pharma, Macleods Pharma, Abbott Vasc., Zydus Cadila, IPCA, Sanofi Aventis, Novo Nordisk, and Emcure Pharma Volume 26–2016 ISBN: 978-93-5250-199-1 © All rights reserved. No part of this book may be reproduced by Xerox, microfilm or any other means without written permission from the editors and publisher. The editors have checked the validity of information provided in the book, and to the best of their knowledge, it is as per the standards accepted at the time of publication. The views and opinions of the authors do not represent the policies of The AssociationJaypee of Physicians of India or the editors. Published by Gurpreet S Wander, KK Pareek Design, Typeset, Print and Distributed by Jaypee Brothers Medical Publishers (P) Ltd Progress in Medicine 2016 (Medicine Update 2016) 1st VOLUME Chief Editors KK Pareek MD Senior Consultant in MedicineBrothers and Director SN Pareek Memorial Hospital and Research Center Kota, Rajasthan, India Gurpreet S Wander MD DM Professor and Head Department of Cardiology Hero DMC Heart Institute Dayanand Medical College and Hospital Ludhiana, Punjab, India Foreword Siddharth -
Autoimmune Diseases, Treatment, and Contact Lens Wear
Autoimmune Diseases, Treatment, and Contact Lens Wear Content written by: June Smith-Jeffries – FCLSA, NCLE, COT Content originally published in the Summer 2015 edition of The Eighth Line Table of Contents • Introduction • Autoimmune Diabetes o Type 1 Diabetes Mellitus o Latent Autoimmune Diabetes of Adulthood (LADA) • Sjögren’s Syndrome • Fibromyalgia • Rheumatoid Arthritis (RA) • Systemic Lupus Erythematosus (SLE) • Ankylosing Spondylitis (AS) • Systemic Sclerosis (Scleroderma) • Raynaud’s Phenomenon • Sarcoidosis • Multiple Sclerosis (MS) • Myasthenia Gravis • Ulcerative Colitis • Corticosteroids and Dilated Eye Exams • Post Test Introduction Autoimmune diseases occur when a person’s immune system does not distinguish between healthy tissue and antigens. An antigen is any substance foreign to the body that evokes an immune response. As a result, the body sets off a reaction that destroys normal tissues. Normally the white blood cells in the body’s immune system help to protect against harmful substances such as bacteria, viruses, toxins, cancer cells and blood and tissue from outside the body. These substances contain antigens. The immune system produces antibodies against these antigens that enable it to destroy these damaging substances. 1 | Page An autoimmune disease may affect one or more organ and various types of tissue. Areas often affected by autoimmune diseases include: connective tissues, joints, muscles, blood vessels, the skin and endocrine glands. There is significant overlap in endocrine and autoimmune diseases because many autoimmune diseases originate in an endocrine gland, for instance, type 2 diabetes, thyroid diseases and Addison’s disease. Autoimmune diseases have been found in virtually every organ system in the body. Most autoimmune diseases continue for the lifetime of the patient because there are no cures. -
Ice Pack Test for Myasthenia Gravis LETTER to the EDITORS
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by RERO DOC Digital Library J Neurol (2003) 250:883–884 DOI 10.1007/s00415-003-1121-1 LETTER TO THE EDITORS Adam Czaplinski countries. According to previous we cooled the more affected eye. Andreas J. Steck publications local cooling improves The ice pack was then removed af- Peter Fuhr neuromuscular transmission, ter 2 minutes. After 10 minutes, whereas warming has the opposite three i. v. injections, one containing effect [1]. However, the precise 10 mg edrophonium and two Ice pack test for mechanism of this effect is unclear. placebo, were administered in a myasthenia gravis Reduction or inhibition of the ac- double blinded fashion by a nurse. tivity of acetylcholinesterase by Photographs were taken immedi- A simple, noninvasive and safe lowering temperature is a possible ately after cooling or 1 minute after diagnostic method mechanism [8]. The purpose of the injection. All pictures were re- present article is to be a reminder viewed by a blinded observer. Out- Received: 24 January 2003 of an alternate method to tensilon come measure was the effect of ice Accepted: 27 February 2003 testing that is simple and safe but or edrophonium on ptosis. seems to have fallen into oblivion Results: Five subjects improved in the neurological literature. with the ice test; however, in one of Sirs: Intravenous injection of the Design/Methods: Five patients them the edrophonium test was acetylcholinesterase inhibitor edro- with ptosis from previously undi- negative. All subjects with positive phonium (tensilon) is commonly agnosed myasthenia gravis and five response to orbital cooling were used in the diagnosis of myasthe- with non-myasthenic ptosis were subsequently shown to have myas- nia gravis (MG), because of rapid studied with the use of tensilon thenia gravis by other tests (ele- onset and short duration of its ef- testing, orbital cooling, and other vated titers of anti-acetylcholine fects. -
Clinical Trial Details (PDF Generation Date :- Thu, 30 Sep 2021 00:31:36 GMT)
PDF of Trial CTRI Website URL - http://ctri.nic.in Clinical Trial Details (PDF Generation Date :- Thu, 30 Sep 2021 00:31:36 GMT) CTRI Number CTRI/2013/12/004264 [Registered on: 31/12/2013] - Trial Registered Retrospectively Last Modified On 10/12/2013 Post Graduate Thesis Yes Type of Trial Interventional Type of Study Drug Study Design Randomized, Parallel Group Trial Public Title of Study Oral glucocorticoids vs. intravenous glucocorticoids in managing thyroid associated orbitopathy Scientific Title of Monthly pulse methylprednisolone vs. oral prednisolone in treatment of thyroid ophthalmopathy: An Study open label randomized controlled trial Secondary IDs if Any Secondary ID Identifier NIL NIL Details of Principal Details of Principal Investigator Investigator or overall Name Dr Subhankar Chowdhury Trial Coordinator (multi-center study) Designation Professor and Head of the Department Affiliation IPGMER and SSKM Hospital Address Department of Endocrinology and Metabolism Room 8, 4th floor, Ronald Ross Building IPGMER and SSKM Hospital 244 AJC Bose Road Calcutta Kolkata WEST BENGAL 700020 India Phone 9831076501 Fax Email [email protected] Details Contact Details Contact Person (Scientific Query) Person (Scientific Name Dr Ajitesh Roy Query) Designation Post-doctoral trainee Affiliation IPGMER and SSKM Hospital Address Room 8, 4th floor, Ronald Ross Building Department of Endocrinology Institute of Post-Graduate Medical Education & Research (IPGMER) Kolkata-700020 Kolkata WEST BENGAL 700020 India Phone 9433135863 Fax Email